Future Market Insights opines that the quillaia extract market stands at a supply-chain inflection, where Chilean origin concentration creates both a competitive moat for GMP-certified producers and a systemic vulnerability for pharmaceutical vaccine adjuvant buyers whose supply security depends on a geographically narrow botanical source base.